United States · Funded startup
Funding summaryUpdated 26 Oct 2026
$146Mraised across 6 rounds since 2005, from 6 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
No investor was named in the report.
From a historical funding recordSEC filing: $21M sold, first sale Mar 2014
Reported by sec.govSEC filing: $10M sold, first sale Apr 2012
No investor was named in the report.
From a historical funding recordSEC filing: $7.5M sold, first sale Aug 2010
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Kleiner Perkins Caufield & Byers
Versant Ventures
TPG
Domain Associates
Advanced Technology Ventures
Pfizer
Wellcome Trust
J.P. Morgan Securities Inc.
Healthcap IX Advisor ABSingapore Bio-InnovationsFrom historical deal records. Wrong? Tell us.
Missing a round, or an investor who was in one? Tell us.
Five Prime Therapeutics's investors include Kleiner Perkins Caufield & Byers, Versant Ventures, TPG, Domain Associates and Advanced Technology Ventures, and 6 more on record.
Five Prime Therapeutics has raised $146M across 6 rounds since 2005. One round did not disclose an amount, so the total is a floor.
Five Prime Therapeutics's most recent round was an Undisclosed round of $21M in Mar 2014.
Five Prime Therapeutics's largest round on record is $62M (Undisclosed round), in Sept 2013.
Five Prime Therapeutics's first round on record, in Feb 2005, was backed by Kleiner Perkins Caufield & Byers, Versant Ventures and TPG and 7 others.
Five Prime Therapeutics's latest named round is an Undisclosed round, in Mar 2014.
Five Prime Therapeutics is based in the United States.
In the same sector, and raised in the last eighteen months.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.
United States · 
